This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
AstraZeneca PLC (AZN.L) – Recordati has entered into an agreement with AstraZeneca for the acquisition of the rights to Seloken, the angina and cardiovascular drug. The consideration for the acquisition of the assets is $300m. In addition, royalties for the use of the existing product brands will be due to AstraZeneca for an agreed period and will be funded by existing liquidity and available credit lines. Closing price 5119.00p (Bloomberg)
UK 100 ( UK 100 Cash), The Dow Jones (Wall Street Cash), De DAX (Germany 30 Cash) – EU ministers meet in Brussels today to refine their Brexit negotiating position after the U.K. threatened to quit talks on its departure unless the bloc drops its demands for a divorce payment as high as €100bn. Keep a watchful eye on sterling today as any breakdown in negotiations could see the UK currency impacted. Current levels 7,498pts, 20,843pts, 12,676pts (Bloomberg / Accendo Markets)
BP PLC (BP.L), Royal Dutch Shell (RDSb.L), Cairn Energy PLC, Premier Oil PLC (PMO.L), Tullow Oil PLC (TLW.L) – Oil futures jumped more than 5% last week amid the prospects of an extended production-cut agreement coming out of this week’s OPEC meeting, prices climb further in early Asian trading. The move, building on gains a week earlier, have pushed crude to its best levels in more than a month. We wait for deal details come out on Thursday. Closing prices 472.15p, 2165.00p, 211.20p, 61.75p, 210.50p (Dow Jones Newswires)
For more information on any of these individual news items, call into the trading floor
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research